ARCHIVES

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Matted Lymph Nodes Can Predict Survival Rate, Spread of Disease

January 27, 2012

Childhood Cancer Survivors May Have Early Heart Problems

July 25, 2003

USLA’’s Steckel Asks More Centers Staff, Strict Enforcement of Guidelines

February 17, 1978

In Brief: Comis Named ECOG Chairman; Long Joins Capitol Associates; Chabner Day In Shelbyville

April 14, 1995

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014